| Serial Number | 99374803 |
| Word Mark | HYPERSYNAPTIKX |
| Filing Date | Thursday, September 4, 2025 |
| Status | 641 - NON-FINAL ACTION - MAILED |
| Status Date | Wednesday, January 28, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Medical laboratory research instruments for evaluating pharmaceuticals, such as antibodies; Plates, glass slides or chips having multi-well arrays that can be used in chemical analysis, biological analysis or patterning for scientific, laboratory or medical research use; Sensor chips for scientific use |
| Goods and Services | Drug discovery services; Pharmaceutical products development; Pharmaceutical research services; Pharmaceutical product evaluation; Pharmaceutical drug development services; Pharmaceutical research and development; Development of pharmaceutical preparations and medicines; Technical research in the field of pharmaceutical studies; Research and development services of new pharmaceutical products; Research and development in the pharmaceutical and biotechnology fields; Research and development services in the field of pharmaceutical preparations; Pharmaceutical research in the field of therapeutic discovery and development; Testing of pharmaceuticals; Laboratory research services relating to pharmaceuticals; Research on the subject of pharmaceuticals; Laboratory research in the field of pharmaceuticals; Development of pharmaceuticals for cell and gene therapies; Testing of pharmaceuticals for cell and gene therapies; Testing, inspection or research of pharmaceuticals, cosmetics or foodstuff; Providing medical research information in the field of pharmaceuticals; Providing scientific research information in the field of pharmaceuticals; Conducting early evaluations in the field of new pharmaceuticals; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Laboratory services for the production of pharmaceuticals in the nature of testing of pharmaceuticals; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Research and development services in the field of antibodies; Medical research; Medical research services; Medical research laboratory services; Medical research in the field of oncology; Medical research in the field of pathology; Medical research in the field of infectious diseases; Medical research in the field of rare diseases; Medical research services in the field of cancer; Medical research laboratory services in the field of oncology; Research and development services in the field of medical preparations; Scientific research for medical purposes in the area of cancerous diseases; Providing information about medical research in the field of therapeutic discovery and development; Medical and scientific research in the field of cancer treatment and diagnosis; Technology research in the field of therapeutic discovery and development; Medical research in the field of therapeutic discovery and development; Research and development in the field of therapeutic discovery and development; Scientific research for medical purposes in the field of therapeutic discovery and development; Medical and scientific research in the field of therapeutic discovery and development; Medical and scientific research information in the field of therapeutic discovery and development; Laboratory services for biomanufacturing; Laboratory services for biomanufacturing of antibodies, peptides, and proteins for therapeutic evaluation; Biological research; Biological research and analysis; Biological research laboratory services; Biological research in the field of therapeutic discovery and development; Research in the field of synthetic biology; Biomedical research services; Biomedical research in the field of therapeutic discovery and development; Biotechnology research; Research and development in the field of biotechnology; Research and development services in the field of biotechnology; Biotechnology research in the field of therapeutic discovery and development |
| International Class | 009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus. |
| US Class Codes | 021, 023, 026, 036, 038 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, September 4, 2025 |
| Primary Code | 009 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, September 4, 2025 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | SPOC Proteomics Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Scottsdale, AZ 85255 |
| Event Date | Event Description |
| Thursday, September 4, 2025 | NEW APPLICATION ENTERED |
| Thursday, September 4, 2025 | APPLICATION FILING RECEIPT MAILED |
| Sunday, January 25, 2026 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, January 26, 2026 | ASSIGNED TO EXAMINER |
| Wednesday, January 28, 2026 | NON-FINAL ACTION WRITTEN |
| Wednesday, January 28, 2026 | NON-FINAL ACTION E-MAILED |
| Wednesday, January 28, 2026 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |